Id
Protein
PTM type
Site
Species
Disease
Celline
Drug
Regulatory
Score
Ref.
acc00101 Putative elongation factor 1-alpha-like 3 oxidation Met410 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00102 Tubulin alpha-1B chain oxidation Met377 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00103 Detyrosinated tubulin alpha-1B chain oxidation Met377 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00104 Tubulin alpha-1B chain oxidation Met302 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00105 Detyrosinated tubulin alpha-1B chain oxidation Met302 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00106 Tubulin beta-4B chain oxidation Met73 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00107 Tubulin beta-4A chain oxidation Met73 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00108 Tubulin beta-8 chain oxidation Met73 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00109 Heterogeneous nuclear ribonucleoprotein D0 oxidation Met215 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00110 Reticulocalbin-1 oxidation Met203 human Breast cancer MDA-MB-468 SU212 Positive 5.0 PXD018929
acc00111 Protein disulfide-isomerase A3 oxidation Met48 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00112 "Actin, cytoplasmic 1" oxidation Met305 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00113 "Actin, cytoplasmic 1, N-terminally processed" oxidation Met305 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00114 "Actin, cytoplasmic 1" oxidation Met227 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00115 "Actin, cytoplasmic 1, N-terminally processed" oxidation Met927 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00116 POTE ankyrin domain family member E oxidation Met227 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00117 Histone H2B type 1-C/E/F/G/I oxidation Met60 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00118 Histone H2B type 1-M oxidation Met60 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00119 Histone H2B type 1-N oxidation Met60 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00120 Histone H2B type 1-H oxidation Met60 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00121 Histone H2B type 2-F oxidation Met60 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00122 Histone H2B type 1-D oxidation Met60 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00123 Histone H2B type 1-K oxidation Met60 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00124 Histone H2B type 1-L oxidation Met60 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00125 Histone H2B type F-S oxidation Met60 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00126 Histone H2B type 2-E oxidation Met60 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00127 Histone H2B type 1-B oxidation Met60 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00128 Histone H2B type 1-O oxidation Met60 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00129 Histone H2B type 1-J oxidation Met60 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00130 Histone H2B type 3-B oxidation Met60 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00131 "Actin, alpha cardiac muscle 1" oxidation Met84 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00132 "Actin, alpha cardiac muscle 1, intermediate form" oxidation Met83 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00133 "Actin, gamma-enteric smooth muscle" oxidation Met84 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00134 "Actin, gamma-enteric smooth muscle, intermediate form" oxidation Met84 human Breast cancer MCF10A SU212 Positive 5.0 PXD018929
acc00135 Transitional endoplasmic reticulum ATPase oxidation Met550 human Breast cancer MCF12A SU212 Negative 5.0 PXD018929
acc00136 "Actin, cytoplasmic 1" oxidation Met47 human Breast cancer MCF12A SU212 Positive 5.0 PXD018929
acc00137 "Actin, cytoplasmic 1, N-terminally processed" oxidation Met48 human Breast cancer MCF12A SU212 Positive 5.0 PXD018929
acc00138 Beta-actin-like protein 2 oxidation Met47 human Breast cancer MCF12A SU212 Positive 5.0 PXD018929
acc00139 "Actin, cytoplasmic 2" oxidation Met49 human Breast cancer MCF12A SU212 Positive 5.0 PXD018929
acc00140 "Actin, cytoplasmic 2, N-terminally processed" oxidation Met49 human Breast cancer MCF12A SU212 Positive 5.0 PXD018929
acc00141 "Actin, alpha cardiac muscle 1" oxidation Met48 human Breast cancer MCF12A SU212 Positive 5.0 PXD018929
acc00142 "Actin, alpha cardiac muscle 1, intermediate form" oxidation Met49 human Breast cancer MCF12A SU212 Positive 5.0 PXD018929
acc00143 "Actin, cytoplasmic 1" oxidation Met305 human Breast cancer MCF12A SU212 Positive 5.0 PXD018929
acc00144 "Actin, cytoplasmic 1, N-terminally processed" oxidation Met305 human Breast cancer MCF12A SU212 Positive 5.0 PXD018929
acc00145 "Actin, cytoplasmic 1" oxidation Met153 human Breast cancer MCF12A SU212 Negative 5.0 PXD018929
acc00146 "Actin, cytoplasmic 1, N-terminally processed" oxidation Met153 human Breast cancer MCF12A SU212 Negative 5.0 PXD018929
acc00147 "Actin, alpha cardiac muscle 1" oxidation Met84 human Breast cancer MCF12A SU212 Positive 5.0 PXD018929
acc00148 "Actin, alpha cardiac muscle 1, intermediate form" oxidation Met84 human Breast cancer MCF12A SU212 Positive 5.0 PXD018929
acc00149 "Actin, alpha skeletal muscle" oxidation Met83 human Breast cancer MCF12A SU212 Positive 5.0 PXD018929
acc00150 "Actin, alpha skeletal muscle, intermediate form" oxidation Met84 human Breast cancer MCF12A SU212 Positive 5.0 PXD018929